ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Free cash flow 2018–2025
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$74.5MFY2025 · since FY2018: -$22.2M → -$74.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$74.5M | -23.4% |
| FY2024 | -$60.4M | -187.6% |
| FY2023 | -$21.0M | -186.5% |
| FY2022 | $24.3M | +117.5% |
| FY2021 | -$138.4M | -210.4% |
| FY2020 | -$44.6M | -514.1% |
| FY2019 | -$7.3M | +67.3% |
| FY2018 | -$22.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARCT financial trends
ARCT RevenueARCT Net incomeARCT Net marginARCT Gross profitARCT Gross marginARCT Operating incomeARCT Operating marginARCT Operating cash flowARCT Capital expendituresARCT Return on equityARCT Stock buybacksARCT Dividends paidARCT Total assetsARCT Total liabilitiesARCT Shareholders’ equityARCT overview →